Empowering Animal Care with Science and Purpose
Zenex Animal Health isn’t just a company, it’s a legacy of innovation, trust, and commitment to better animal healthcare. Over the last 60+ years, we’ve pioneered breakthrough solutions for livestock, poultry, and companion animals, helping veterinarians and farmers improve productivity and well-being. Today, as we expand globally, our mission remains the same, to push the boundaries of veterinary science while staying rooted in quality and care.
0
+Decades of Operational Expertise
0
+Brands in Product Portfolio
0
cGMP
Approvals
0
+Employee
Strength
Our Purpose, Your Trust
We enhance animal well-being through innovation, care, and science, providing trusted solutions for veterinarians, farmers, and pet owners.
Our Vision
To be amongst the most valued Global Animal Health companies for Animal healthcare professionals; Livestock, Poultry, Aquaculture farmers, Companion animal owners and all other stakeholders.
Our Mission
We shall provide comprehensive healthcare, help improve productivity of animals and birds through safe, innovative, quality products & services.
What Drives Us
At Zenex Animal Health, our values guide everything we do—from scientific innovation to everyday teamwork. They shape our culture, drive our mission, and ensure that we create real impact in the world of animal health.
Diversity, Equity & Inclusion
Fostering a culture of respect, inclusion and equity
Quick Adaptability
Keeping pace with change
Innovation
Being innovative in all that we do
Delivering Excellence
Ensuring the best, always
Collaboration
‘WE’ before ‘I’
A Story of Innovation, Growth, and Commitment
Founded in 2021 as an independent company, Zenex Animal Health builds on over six decades of expertise in animal healthcare. With a focus on research, innovation, and sustainability, we’re shaping the future of veterinary science.
Guiding the Future of Veterinary Science
At the heart of Zenex Animal Health is a team that brings expertise, vision, and passion for transforming animal healthcare.
Renuka is Chairperson of Zenex Animal Health India Pvt Ltd. and the Founder, Managing Director, and CEO of Multiples Alternate Asset Management Private Limited (Multiples), a private equity manager and advisor to Funds with AUM of over US$ 3 billion.
With over 35 years in financial services, she has deep experience in private equity, investment banking, and structured finance. She previously served as MD & CEO of ICICI Venture, building it into one of India’s largest private equity funds before founding Multiples in 2009.
Renuka is passionate about empowering entrepreneurs to build sustainable businesses that drive employment and economic growth. She serves on the board of GPCA and chaired the Executive Committee of IVCA (2020–2022).
She’s been featured in prestigious lists like Business Today’s Top 25 Most Powerful Women and Forbes Top 50 Achievers in Business. She holds a Bachelor of Engineering from VJTI, an MBA from the University of Mumbai, and has completed the AMP at Harvard Business School.
Dr. Arun Atrey serves as the Managing Director and CEO of Zenex Animal Health India Private Limited. With an impressive four decades of experience, including 37 years of dedicated service to the Zydus Cadila Group (now Zydus Lifesciences), Dr. Atrey brings a wealth of expertise to his role.
With a degree in Veterinary Science and a postgraduate degree in Business Management (University Topper & Gold Medallist), his remarkable journey began in 1985 when he joined Cadila Veterinary as a Product Executive after a short stint in the FMCG industry. He was given the complete responsibility for building the animal health business of Cadila in 1986 as its Marketing Manager and Head of Marketing. He was pivotal in the joint venture between Zydus Cadila and Ambalal Sarabhai Enterprises Ltd. in 2000. He continued to lead the new JV as its COVO and Wholetime Director.
Under Dr. Atrey’s leadership, Zydus Cadila achieved significant milestones — introducing numerous ground-breaking veterinary products to the Indian market. These achievements led to Zydus Animal Health being recognised as the best Animal Health Company in India, the Middle East and Africa by Animal Pharm, UK in 2015, 2017 and 2018. In addition, the Company received prestigious awards such as ‘The Best Poultry Company Award’ in 2010 (IPJA) and 2014 (Poultry Fortune), among others.
Post creation of Zenex Animal Health, the organisation continued to receive several awards such as Best Company in the ‘Rest of the World’ from S&P Global, Best Poultry Healthcare Company Award 2023 received from NRS Publications and Corporate Leadership Award received at the 2nd Animal Health Summit in 2023. The acquisition of the India’s leading herbal Company, Ayurvet and its structured integration, is a testimony to the Dr Atrey’s ability to drive strategic growth and navigate the complex market dynamics in India and globally.
Dr. Arun Atrey actively engages in the animal health industry. He is a Founder Director and Past President (2015-2017) of INFAH (Indian Federation of Animal Health Companies). He is also the Chairman of the ‘Therapeutic & Disinfectant Subcommittee’ of INFAH. His contributions to the industry have been recognised through honours and awards, including the ‘Best CEO in the Poultry Industry 2018 Award’ instituted by the Poultry Fortune Group.
Dr. Atrey’s insights and expertise make him a sought-after speaker at industry forums, management and veterinary institutes. He is also a member of the expert committee of the IPC veterinary group.
Our Visionary Team
Manish has been an investment professional for ~20 years focused on identifying and nurturing investments across listed and unlisted universe. Manish joined Multiples Alternate Asset Management Private Limited, a private equity manager and advisor to Funds with AUM of over US$ 3 billion in 2019.
Prior to joining Multiples, he spent 14+ years with The Carlyle Group, where he worked in Carlyle’s Asia Growth Capital as well as Buyout teams focusing on investments across sectors such as pharmaceuticals, technology and business services, consumer and industrials. Prior to that, Manish spent time at Credit Suisse and Deutsche Bank as part of their top-rated equity research teams.
As Managing Director – Enterprise Technology and Pharma, Manish leads investments across pharmaceutical, healthcare, enterprise tech, industrials and logistics sectors from Multiples platform.
Manish holds a post-graduate diploma in management from the Indian Institute of Management (IIM), Ahmedabad and a Bachelor of Technology degree from the Indian Institute of Technology (IIT), Bombay. He is also a CFA charter holder.
Mr Sheth is the Founder and Mentor of TRUST Group. TRUST Group is an institutionalized multi-line and multi-asset financial services platform with leadership in the debt capital markets and a differentiated advisory, asset, and wealth management platform.
Mr Utpal Sheth was the former CEO and Senior Partner at RARE Enterprises, a multi-billion-dollar proprietary asset management firm based in India. Mr Sheth focuses on long-term investing in public and private markets, portfolio construction, and risk management.
He regularly engages with investee companies to enhance shareholder value by emphasizing sustainable value drivers. In a career of over 30 years in the capital markets across various reputed Indian financial firms, he has extensive experience in investment management, fundraising, M&A, buybacks, and corporate advisory.
Andrew Yee joined IFC’s Asset Management Company in 2014 as Co- Head of the Emerging Asia Fund, overseeing more than 20 equity investments across a diverse range of companies and industries in India, Sri Lanka, Bangladesh, the Philippines, Vietnam, Indonesia, China and Myanmar.
With over three decades of experience in private equity, industry and banking in Asia, Australia and Europe, Andrew brings diverse, international and impactful insights to each investment. Prior to IFC, he held key positions at Standard Chartered Bank Private Equity in Singapore, Inter Gen Asia and Goldman Sachs in Hong Kong. His expertise in infrastructure investments and his strategic contributions to the industry have been widely acknowledged.
Andrew holds a Bachelor of Commerce degree (majoring in Accounting) and a Bachelor of Laws degree from the University of New South Wales in Sydney, Australia.
With 40+ years of vast experience in Life sciences industry, an inveterate traveller, a great number cruncher turned an entrepreneur who knows how to back the right Start-ups. Held senior positions at Glaxo, Becton Dickinson and Ranbaxy. Led the management buyout (MBO) of allied business of Ranbaxy by ICICI Venture in 2005.
As CEO of new formed enterprise RFCL he divested the business by 2011 creating handsome returns for stakeholders. In 2011 after being acquired by Avantor Performance Material, Inc through New Mountain Capital (a New York based PE fund) was part of the Global leadership team.
Post retirement he turned into an Angel Investor with an aim to associate with Start-ups and help them build teams, to achieve operational excellence resulting in quantum growth. Currently Chairman and majority shareholder of NGIVD (an In-vitro Diagnostics company) and also on board of QNu Labs, Bangalore (a cybersecurity start-up).
Advanced Infrastructure for Trusted Quality
Zenex Animal Health operates two state-of-the-art manufacturing facilities, setting us apart as the only large company in India with specialized setups for veterinary products including herbal products.
Specializing in pharmaceutical formulations, with WHO-GMP certification and international regulatory approvals
Produces a wide range of formulations, including injectables, oral liquids, powders, tablets, and boluses.
Ensures product consistency and safety through advanced quality control systems and state-of-the-art equipment.
Specializing in herbal feed supplements and ayurvedic veterinary products, catering to growing demand for natural solutions
Produces bolus, capsules, liquids, gels, and powders to support diverse healthcare needs.
ISO 9001-2015 certified, with a DSIR-approved R&D facility and an AYUSH-certified Quality Control Lab, ensuring product safety and efficacy systems and state-of-the-art equipment.
Caring for Animals, Communities, and the Planet
Setting New Benchmarks in Animal Healthcare
Our unwavering commitment to innovation has earned us recognition as a leader in veterinary healthcare. Every accolade is a testament to the dedication of our teams and our commitment to advancing veterinary science.
